APA (7th ed.) Citation

Kloor, M., Reuschenbach, M., Pauligk, C., Heider, J., Rafiyan, M., Batran, S. a., . . . Knebel Doeberitz, M. v. (2020). A frameshift peptide neoantigen-based vaccine for mismatch repair-deficient cancers: A phase I/IIa clinical trial. Clinical cancer research, 26(17), . https://doi.org/10.1158/1078-0432.CCR-19-3517

Chicago Style (17th ed.) Citation

Kloor, Matthias, Miriam Reuschenbach, Claudia Pauligk, Julia Heider, Mohammad-Reza Rafiyan, Salah-Eddin al- Batran, Mirjam Tariverdian, Elke Jäger, and Magnus von Knebel Doeberitz. "A Frameshift Peptide Neoantigen-based Vaccine for Mismatch Repair-deficient Cancers: A Phase I/IIa Clinical Trial." Clinical Cancer Research 26, no. 17 (2020). https://doi.org/10.1158/1078-0432.CCR-19-3517.

MLA (9th ed.) Citation

Kloor, Matthias, et al. "A Frameshift Peptide Neoantigen-based Vaccine for Mismatch Repair-deficient Cancers: A Phase I/IIa Clinical Trial." Clinical Cancer Research, vol. 26, no. 17, 2020, https://doi.org/10.1158/1078-0432.CCR-19-3517.